The PI3K-independent reactivation of AKT has been reported in KRAS-mutated NSCLC cells [120,121,122], glioblastoma cells [123], bladder cancer cells [124], and TNBC cells [125] after the blockade of PI3K. This evidence concerns the gene AKT1 and urinary bladder cancer.